Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dembot
    Junior Member
    • Feb 2014
    • 4

    #1

    Very basic cuffdiff normalization question

    Hi Folks --

    I'm a bit confused about the method that cuffdiff uses to normalize expression levels between the two (or more) conditions that you feed it. I generally use geometric normalization, but am unclear whether this means that normalization is dependent on the expression levels in your conditions, or whether it's tied to some independent factor that's constant regardless of what conditions you feed to cuffdiff.

    e.g. Say we have GeneX, to which we want to normalize, with FPKM in Condition 1 = 10, and FPKM in sample 2 = 20. Cuffdiff could normalize in one of two ways:

    1) Multiply all FPKM values in Condition 1 or divide all values in Condition 2 by a factor of 2, so that GeneX's FPKM is the same in both conditions.

    2) Knowing that, on average, GeneX is usually around 30, cuffdiff could multiply the FPKM's in each condition so that, again, GeneX is the same in both conditions.

    I'm curious about this because if normalization is done the first way, this means that you can only compare FPKM values between conditions that have been paired together in cuffdiff. However, if (2) is true, this means that you can compare FPKM values between conditions that were NOT directly paired in cuffdiff. Put another way, if (2) is true, this means that the FPKM value for a given gene and condition is an absolute measure of enrichment in that condition. I've noticed, generally speaking, that my FPKM value for a given gene and condition tends to be pretty stable, regardless of what other condition I pair it with in cuffdiff (e.g. GeneX from Sample 1 = 10, regardless of whether Sample 1 is paired with Sample 2 or Sample 3).

    Does this mean that, if I notice GeneY = 50 in Condition 1 (when I compare condition 1 to condition 2), but equals zero in all other conditions (e.g. condition 2 vs. 3, 4 vs. 5), that I can make any definitive statement about GeneY being higher in condition 1 than conditions 3, 4 or 5 (which I have not compared condition 1 to directly)?
    Last edited by dembot; 05-21-2014, 08:54 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...